Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.

Saved in:
Bibliographic Details
Title: Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
Authors: Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Rodriguez-Roisin R; Universitat de Barcelona, Hospital Clínic-The August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Reisner C; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA.; AstraZeneca, Gaithersburg, MD, USA., Maes A; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA., Siddiqui S; AstraZeneca, Gaithersburg, MD, USA., Martin UJ; AstraZeneca, Gaithersburg, MD, USA.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2018 Mar 21; Vol. 13, pp. 945-953. Date of Electronic Publication: 2018 Mar 21 (Print Publication: 2018).
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29606861
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferguson+GT%22">Ferguson GT</searchLink>; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Roisin+R%22">Rodriguez-Roisin R</searchLink>; Universitat de Barcelona, Hospital Clínic-The August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Reisner+C%22">Reisner C</searchLink>; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA.; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Maes+A%22">Maes A</searchLink>; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Siddiqui+S%22">Siddiqui S</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Martin+UJ%22">Martin UJ</searchLink>; AstraZeneca, Gaithersburg, MD, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101273481%22">International journal of chronic obstructive pulmonary disease</searchLink> [Int J Chron Obstruct Pulmon Dis] 2018 Mar 21; Vol. 13, pp. 945-953. <i>Date of Electronic Publication: </i>2018 Mar 21 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22DOVE+Medical+Press%22">DOVE Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101273481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1178-2005 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211769106%22">11769106 </searchLink><i>NLM ISO Abbreviation: </i>Int J Chron Obstruct Pulmon Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29606861
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/COPD.S154988
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 945
    Titles:
      – TitleFull: Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferguson GT
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Roisin R
      – PersonEntity:
          Name:
            NameFull: Reisner C
      – PersonEntity:
          Name:
            NameFull: Maes A
      – PersonEntity:
          Name:
            NameFull: Siddiqui S
      – PersonEntity:
          Name:
            NameFull: Martin UJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 03
              Text: 2018 Mar 21
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1178-2005
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: International journal of chronic obstructive pulmonary disease
              Type: main
ResultId 1